To illustrate the use of this method in primary microglia we have knocked down the expression of TREM2 and CD33, two important genes whose mutations are considered a risk factor to develop AD (Griciuc et al., 2013; Colonna and Wang, 2016). This evidence concerns the gene TREM2 and Alzheimer disease.